Sandy Spring Bank’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $17K | Sell |
100
-49
| -33% | -$8.51K | ﹤0.01% | 763 |
|
|
2024
Q4 | $24.8K | Hold |
149
| – | – | ﹤0.01% | 713 |
|
|
2024
Q3 | $25.6K | Hold |
149
| – | – | ﹤0.01% | 712 |
|
|
2024
Q2 | $22.9K | Hold |
149
| – | – | ﹤0.01% | 733 |
|
|
2024
Q1 | $22.9K | Sell |
149
-160
| -52% | -$24.4K | ﹤0.01% | 723 |
|
|
2023
Q4 | $48.8K | Hold |
309
| – | – | ﹤0.01% | 568 |
|
|
2023
Q3 | $45.2K | Hold |
309
| – | – | ﹤0.01% | 560 |
|
|
2023
Q2 | $47.3K | Hold |
309
| – | – | ﹤0.01% | 556 |
|
|
2023
Q1 | $47.9K | Hold |
309
| – | – | ﹤0.01% | 538 |
|
|
2022
Q4 | $47.6K | Hold |
309
| – | – | ﹤0.01% | 539 |
|
|
2022
Q3 | $41K | Hold |
309
| – | – | ﹤0.01% | 539 |
|
|
2022
Q2 | $42K | Hold |
309
| – | – | ﹤0.01% | 542 |
|
|
2022
Q1 | $46K | Hold |
309
| – | – | ﹤0.01% | 557 |
|
|
2021
Q4 | $50K | Hold |
309
| – | – | ﹤0.01% | 569 |
|
|
2021
Q3 | $51K | Hold |
309
| – | – | ﹤0.01% | 550 |
|
|
2021
Q2 | $53K | Hold |
309
| – | – | ﹤0.01% | 553 |
|
|
2021
Q1 | $50K | Hold |
309
| – | – | ﹤0.01% | 511 |
|
|
2020
Q4 | $52K | Hold |
309
| – | – | ﹤0.01% | 481 |
|
|
2020
Q3 | $49K | Hold |
309
| – | – | ﹤0.01% | 460 |
|
|
2020
Q2 | $52K | Sell |
309
-100
| -24% | -$15.7K | ﹤0.01% | 455 |
|
|
2020
Q1 | $54K | Hold |
409
| – | – | ﹤0.01% | 427 |
|
|
2019
Q4 | $61K | Hold |
409
| – | – | ﹤0.01% | 442 |
|
|
2019
Q3 | $51K | Hold |
409
| – | – | ﹤0.01% | 466 |
|
|
2019
Q2 | $58K | Sell |
409
-100
| -20% | -$13.8K | ﹤0.01% | 439 |
|
|
2019
Q1 | $77K | Hold |
509
| – | – | 0.01% | 392 |
|
|
2018
Q4 | $63K | Hold |
509
| – | – | 0.01% | 414 |
|
|
2018
Q3 | $81K | Hold |
509
| – | – | 0.01% | 398 |
|
|
2018
Q2 | $71K | Hold |
509
| – | – | 0.01% | 422 |
|
|
2018
Q1 | $68K | Sell |
509
-210
| -29% | -$28.7K | 0.01% | 426 |
|
|
2017
Q4 | $90K | Hold |
719
| – | – | 0.01% | 358 |
|
|
2017
Q3 | $89K | Hold |
719
| – | – | 0.01% | 356 |
|
|
2017
Q2 | $82K | Sell |
719
-95
| -12% | -$10.2K | 0.01% | 380 |
|
|
2017
Q1 | $86K | Hold |
814
| – | – | 0.01% | 369 |
|
|
2016
Q4 | $74K | Buy |
814
+714
| +714% | +$66.9K | 0.01% | 391 |
|
|
2016
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 641 |
|
|
2016
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 674 |
|
|
2016
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 682 |
|
|
2015
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 632 |
|
|
2015
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 647 |
|
|
2015
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 663 |
|
|
2015
Q1 | $12K | Buy |
+100
| New | +$11.3K | ﹤0.01% | 650 |
|
Other funds holding FBT
BFG
SFGP
Sandy Spring Bank's FBT Position: Q1 2025 in Review
Sandy Spring Bank reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 33% in Q1 2025, selling an estimated $8.51K and leaving 100 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #763.
Sandy Spring Bank first reported a position in FBT in Q1 2015 and has held it in 41 quarters since. The position peaked at $90K in Q4 2017. 269 funds tracked by Wall St. Rank hold FBT as of Q1 2025.
- Sandy Spring Bank held 100 shares of First Trust NYSE Arca Biotechnology Index Fund worth $17K as of Q1 2025.
- Sandy Spring Bank sold 49 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2025, an estimated $8.51K.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #763 holding.
- Sandy Spring Bank first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and has held it in 41 quarters since.
- Sandy Spring Bank's First Trust NYSE Arca Biotechnology Index Fund position peaked at $90K in Q4 2017.
- 269 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2025.
Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.